Because the combined deletion of Ldlr and Ceacam1 is not expected to alter insulin sensitivity [5], this model will predictably test whether hypercholesterolemia causes atherosclerosis in the absence of insulin resistance. Here, CEACAM1 is linked to atherosclerosis.